IRME OTC
IR-Med Inc.
1W: +0.0%
1M: +0.0%
3M: -70.0%
YTD: -94.8%
1Y: -95.6%
3Y: -99.6%
5Y: -99.9%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$21K
-23.5% ▼
Operating Income
-$2M
+60.5% ▲
Net Income
-$2M
+61.3% ▲
EPS (Diluted)
$-0.03
+62.0% ▲
EBITDA
-$2M
+61.7% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $1K | $5K | $10K | $17K | $21K |
| Gross Profit | -$1K | -$5K | -$10K | -$17K | -$21K |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $409K | $1M | $2M | $2M | $710K |
| SG&A Expenses | $316K | $2M | $3M | $3M | $1M |
| Operating Expenses | $730K | $4M | $5M | $5M | $2M |
| Operating Income | -$730K | -$4M | -$5M | -$5M | -$2M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $9K | $5K | $6K | $0 | $3K |
| Income Before Tax | -$752K | -$4M | -$5M | -$5M | -$2M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$761K | -$4M | -$9M | -$5M | -$2M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.03 | $-0.06 | $-0.14 | $-0.07 | $-0.03 |
| EBITDA | -$729K | -$4M | -$5M | -$5M | -$2M |
| Shares Outstanding | 30M | 63M | 68M | 69M | 70M |